• Issue

    Pediatric Blood & Cancer: Volume 60, Issue 4

    527-712
    April 2013
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Highlights

How many physicians do we need? A benchmark for pediatric hematology/oncology

Patrick J. Leavey MD, 
  • Pages: 527-528
  • First Published: 14 November 2012

Increasing exercise in long-term survivors of pediatric cancer and their siblings: Should treatment be a family affair?

Rudolf Steiner MD, 
  • Pages: 529-530
  • First Published: 17 January 2013

Priority Reports

The impact of the written request process on drug development in childhood cancer

Kristen M. Snyder MD,  Gregory Reaman MD,  Debbie Avant PhD,  Richard Pazdur MD, 
  • Pages: 531-537
  • First Published: 17 January 2013

Clinical Practice Guidelines

Free Access

The management of children with Kaposi sarcoma in resource limited settings

Elizabeth Molyneux FRCPCH,  Alan Davidson MPhil,  Jackson Orem MMed,  Peter Hesseling PhD,  Joyce Balagadde-Kambugu MPhil,  Jessie Githanga MMedPath,  Trijn Israels PhD, 
  • Pages: 538-542
  • First Published: 19 December 2012
Free Access

A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group†

Leontien C.M. Kremer MD, PhD,  Renée L. Mulder MSc,  Kevin C. Oeffinger MD,  Smita Bhatia MD, MPH,  Wendy Landier RN, PhD,  Gill Levitt MD,  Louis S. Constine MD,  W. Hamish Wallace MD,  Huib N. Caron MD, PhD,  Saro H. Armenian MD, MPH,  Roderick Skinner MB, PhD,  Melissa M. Hudson MD, 
  • Pages: 543-549
  • First Published: 31 December 2012

Reviews

Potential role for statins in sickle cell disease†‡

Soheir S. Adam MD,  Carolyn Hoppe MD, 
  • Pages: 550-557
  • First Published: 31 December 2012

Decision making in pediatric oncology: Evaluation and incorporation of patient and parent preferences

Lillian Sung MD, PhD,  Dean A. Regier PhD, 
  • Pages: 558-563
  • First Published: 31 December 2012

Research Articles

Establishing physician to patient ratios and predicting workforce needs for Canadian pediatric hematology-oncology programs†‡

Jacqueline M. Halton MD,  Jack Hand MD,  Patricia Byron MSN,  Douglas Strother MD,  Victor Blanchette FRCP,  for the C17 Council of Canadian Pediatric Hematology Oncology, Transplantation Directors , 
  • Pages: 564-569
  • First Published: 05 October 2012

Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome†

Vivian Y. Chang MD, MS,  Noah Federman MD,  Julian Martinez-Agosto MD, PhD,  Sergei F. Tatishchev MD,  Stanley F. Nelson MD, 
  • Pages: 570-574
  • First Published: 26 September 2012

Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts†

Krithi Rao-Bindal PhD,  Chethan K. Rao,  Ling Yu MD, PhD,  Eugenie S. Kleinerman MD, 
  • Pages: 575-579
  • First Published: 19 December 2012

Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung†

Alexander J. Chou MD,  Renu Gupta MD,  Moshe D. Bell MD,  Kathleen O'Day Riewe MD,  Paul A. Meyers MD,  Richard Gorlick MD, 
  • Pages: 580-586
  • First Published: 19 December 2012

Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials†

Furqan Shaikh MD,  Paul C. Nathan MD,  Juliet Hale MD,  Elizabeth Uleryk BA, MLS,  Lindsay Frazier MD, 
  • Pages: 587-592
  • First Published: 13 September 2012

Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma†

Surya Rednam MD,  Michael E. Scheurer PhD, MPH,  Adekunle Adesina MD, PhD,  Ching C. Lau MD, PhD,  Mehmet Fatih Okcu MD, MPH, 
  • Pages: 593-598
  • First Published: 12 October 2012

Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy†

Fariba Ghassemi MD,  Elham Rahmanikhah MD,  Ramak Roohipoor MD,  Reza Karkhaneh MD,  Adeleh Faegh MD, 
  • Pages: 599-604
  • First Published: 03 October 2012

Symptom interval in pediatric patients with solid tumors: Adolescents are at greater risk of late diagnosis†

Laura Veneroni MS,  Luigi Mariani MD,  Salvatore Lo Vullo BSc,  Francesca Favini MD,  Serena Catania MD,  Marco Vajna de Pava MD,  Maura Massimino MD,  Andrea Ferrari MD, 
  • Pages: 605-610
  • First Published: 03 October 2012

Clinical features and outcomes in patients with secondary Ewing sarcoma†‡

Mark A. Applebaum MD,  Robert Goldsby MD,  John Neuhaus PhD,  Steven G. DuBois MD, 
  • Pages: 611-615
  • First Published: 27 July 2012

Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: Analysis of a national cohort of patients in the pediatric health information systems database†

Dana M. Walker MD, MSCE,  Brian T. Fisher DO, MSCE,  Alix E. Seif MD, MPH,  Yuan-Shung V. Huang MS,  Kari Torp,  Yimei Li PhD,  Richard Aplenc MD, PhD, 
  • Pages: 616-620
  • First Published: 04 September 2012

Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia†‡

Eric J. Chow MD, MPH,  Catherine Pihoker MD,  Debra L. Friedman MD, MS,  Stephanie J. Lee MD, MPH,  Jeannine S. McCune PharmD,  Claire Wharton BS,  Christian L. Roth MD,  K. Scott Baker MD, MS, 
  • Pages: 621-626
  • First Published: 05 October 2012

A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study†

Susan M. Blaney MD,  Michael Tagen PharmD,  Arzu Onar-Thomas PhD,  Stacey L. Berg MD,  Sri Gururangan MRCP (UK),  Kathleen Scorsone PhD,  Jack Su MD,  Stewart Goldman MD,  Mark W. Kieran MD, PhD,  Larry Kun MD,  Jim Boyett PhD,  Clinton Stewart PharmD, 
  • Pages: 627-632
  • First Published: 21 September 2012

Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program†

Hernan Carol PhD,  C. Patrick Reynolds MD, PhD,  Min H. Kang PharmD,  Stephen T. Keir PhD,  John M. Maris MD,  Richard Gorlick MD,  E. Anders Kolb MD,  Catherine A. Billups MS,  Brian Geier MS,  Raushan T. Kurmasheva PhD,  Peter J. Houghton PhD,  Malcolm A. Smith MD, PhD,  Richard B. Lock PhD, 
  • Pages: 633-641
  • First Published: 02 July 2012

Malnutrition in pediatric patients with cancer at diagnosis and throughout therapy: A multicenter cohort study†

Karin Zimmermann MSc, RN,  Roland A. Ammann MD,  Claudia E. Kuehni MD,  Sabina De Geest PhD, RN,  Eva Cignacco PhD, RM, 
  • Pages: 642-649
  • First Published: 31 December 2012

High rates of recurrent biliary tract obstruction in children with sickle cell disease†

Martha O. Amoako MD,  James F. Casella MD,  John J. Strouse MD, PhD, 
  • Pages: 650-652
  • First Published: 19 December 2012

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease†

Suzette O. Oyeku MD, MPH,  M. Catherine Driscoll MD,  Hillel W. Cohen DrPH, MPH,  Rebecca Trachtman BA,  Farzana Pashankar MD,  Craig Mullen MD, PhD,  Patricia J. Giardina MD,  Nerissa Velazco BS,  Andrew D. Racine MD, PhD,  Nancy S. Green MD, 
  • Pages: 653-658
  • First Published: 05 November 2012

The impact of genetic and environmental factors on homocysteine levels in preterm neonates†

Ayala Maayan-Metzger,  Aaron Lubetsky,  Jacob Kuint,  Nurit Rosenberg,  Michal J. Simchen,  Amir Kuperman,  Tzipora Strauss,  Ben-Ami Sela,  Gili Kenet MD, 
  • Pages: 659-662
  • First Published: 28 September 2012

Exercise capacity in long-term survivors of pediatric cancer: An analysis from the cardiac risk factors in childhood cancer survivors study†

Angela M. Miller MSPH,  Gabriela Lopez-Mitnik MS,  Gabriel Somarriba DPT,  Stuart R. Lipsitz DSc,  Andrea S. Hinkle MD,  Louis S. Constine MD,  Steven E. Lipshultz MD,  Tracie L. Miller MD, 
  • Pages: 663-668
  • First Published: 19 December 2012

An fMRI investigation of working memory and its relationship with cardiorespiratory fitness in pediatric posterior fossa tumor survivors who received cranial radiation therapy†

Kelly R. Wolfe MA,  Avi Madan-Swain PhD,  Gary R. Hunter PhD,  Alyssa T. Reddy MD,  James Baños PhD,  Rajesh K. Kana PhD, 
  • Pages: 669-675
  • First Published: 05 October 2012

Acute onset of ovarian dysfunction in young females after start of cancer treatment†‡

Helena Mörse MD,  Maria Elfving MD, PhD,  Anna Lindgren MSc, PhD,  Pål Wölner-Hanssen MD, PhD,  Claus Yding Andersen MSc, PhD,  Ingrid Øra MD, PhD, 
  • Pages: 676-681
  • First Published: 26 September 2012

New health conditions identified at a regional childhood cancer survivor clinic visit†

Mary-Jane Staba Hogan MD, MPH,  Xiaomei Ma PhD,  Nina S. Kadan-Lottick MD, MSPH, 
  • Pages: 682-687
  • First Published: 28 September 2012

Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage†‡

Jesse L. Berry MD,  Rima Jubran MD,  Jonathan W. Kim MD,  Kenneth Wong MD,  Simon R. Bababeygy MD,  Hashem Almarzouki MD,  Thomas C. Lee MD,  A. Linn Murphree MD, 
  • Pages: 688-693
  • First Published: 19 September 2012

Long-term medical outcomes in survivors of extra-ocular retinoblastoma: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience†

Danielle Novetsky Friedman MD,  Charles A. Sklar MD,  Kevin C. Oeffinger MD,  Nancy A. Kernan MD,  Yasmin Khakoo MD,  Brian P. Marr MD,  Suzanne L. Wolden MD,  David H. Abramson MD,  Ira J. Dunkel MD, 
  • Pages: 694-699
  • First Published: 21 August 2012

Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age†‡

Jean M. Mulcahy Levy MD,  Tiffany Tello MD,  Roger Giller MD,  Greta Wilkening PsyD,  Ralph Quinones MD,  Amy K. Keating MD,  Arthur K. Liu MD, PhD, 
  • Pages: 700-704
  • First Published: 27 July 2012

Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS†

Angela R. Smith MD, MS,  Ellen C. Christiansen BA,  John E. Wagner MD,  Qing Cao PhD,  Margaret L. MacMillan MD,  Heather E. Stefanski MD, PhD,  Barbara A. Trotz BS,  Michael J. Burke MD,  Michael R. Verneris MD, 
  • Pages: 705-710
  • First Published: 14 November 2012

Letter to the Editor

Mediastinal extramedullary hematopoiesis mimicking a neuroblastic tumor in a patient with beta-thalassemia

Ernesto Montaruli MD,  Francesca Marchetti Rosa MD,  Anu Paul MD,  Hélène Martelli MD, PhD,  Catherine Guettier MD, PhD,  Christelle Dufour MD,  Florent Guérin MD, 
  • Pages: 711-712
  • First Published: 09 January 2013